THOMAS H. GLOCER - 31 Mar 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: Director
Signature: /s/ Kelly E. W. Grez as Attorney-in-Fact for Thomas H. Glocer
Issuer symbol: MRK
Transactions as of: 31 Mar 2022
Net transactions value: +$11,250
Form type: 4
Filing time: 01 Apr 2022, 13:38:00 UTC
Previous filing: 04 Jan 2022
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						5,100	31 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Phantom Stock	Award	$11,250	+137	+0.17%	$82.05	80,715	31 Mar 2022	Common Stock	137		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1-for-1
F2	Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3	Holdings include shares acquired in dividend reinvestment transactions.